Market Size of Alginate Dressing Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 0.82 Billion |
| Market Size (2029) | USD 1 Billion |
| CAGR (2024 - 2029) | 4.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Alginate Dressing Market Analysis
The Alginate Dressing Market size is estimated at USD 0.82 billion in 2024, and is expected to reach USD 1 billion by 2029, growing at a CAGR of 4.10% during the forecast period (2024-2029).
Growing cases of chronic wounds, such as diabetes and pressure ulcers, are driving the expansion of the alginate dressing market. Increased surgical procedures also drive demand for effective wound care solutions. The growing aging population, which often experiences slower wound healing, further boosts the need for alginate dressings.
Chronic wounds, including diabetic foot ulcers and pressure ulcers, are on the rise. These wounds require specialized care, and alginate dressings, known for their ability to manage exudate and promote healing, are likely to drive the market growth. According to the article published in JAMA Network in July 2023, approximately 18.6 million people across the globe are affected by diabetic foot ulcers each year, including 1.6 million people in the United States. Additionally, as per data published by National Health Services in May 2024, a total of 122,030 ulcer episodes in 106,880 people with diabetes were registered with the National Diabetes Foot Audit during 2022-2023 in the United Kingdom. Thus, the annual incidence of diabetic foot ulcers is expected to increase demand for alginate wound dressing and is likely to contribute to market growth over the forecast period.
Furthermore, the increasing prevalence of attributed factors like the aging population and rising diabetes rates often lead to complications like diabetic foot ulcers. For instance, according to the 2022 update from the International Diabetic Federation (IDF), around 537 million adults aged 20-79 are currently living with diabetes across the globe. Projections indicate that this number will increase to 643 million by 2030 and reach 783 million by 2045. Consequently, the rising prevalence of diabetic foot ulcers is anticipated to drive growth in the wound dressing industry. Thus, the prevalence of diabetes is rising, leading to more diabetic ulcers. Alginate dressings are particularly beneficial for these types of wounds due to their moisture-retentive properties and ability to absorb large amounts of exudate, driving the market growth.
The increase in surgical procedures and wounds representing the most significant wound subset is contributing to the demand for alginate wound dressing products. For instance, as per the report published by the Journal of Orthopaedic Science in January 2023, the number of hip arthroplasties in Japan in 2030 is predicted to be 8,936 in men aged 40–64 years, 9,005 in men aged 65–74 years, 5,972 in men aged ≥75 years, 27,327 in women aged 40–64 years, 36,416 in women aged 65–74 years, and 37,011 in women aged ≥75 years. This shows the significantly high number of hip arthroplasties in Japan, which is expected to drive the demand for alginate wound dressing to enhance hip implant longevity, promote bone integration, and facilitate post-operative healing, thereby contributing to market growth.
Therefore, the alginate dressing market is positively impacted by the growing incidence of chronic wounds, higher surgical volumes, and an increasing diabetic population. However, the high cost of alginate dressing and lack of proper reimbursement are anticipated to hamper the market growth.
